GLYTRIN

This brand name is authorized in Austria, Ireland, New Zealand, Singapore, UK.

Active ingredients

The drug GLYTRIN contains one active pharmaceutical ingredient (API):

1	Glycerol trinitrate UNII G59M7S0WS3 - NITROGLYCERIN
	Glycerol has uses as a hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as an eye drop in the treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate the bowel prior to a colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer.
	Read more about Glycerol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GLYTRIN Sublingual spray, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01DA02	Glyceryl trinitrate	C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	183506
IE	Health Products Regulatory Authority	26700
NZ	Medicines and Medical Devices Safety Authority	9844
SG	Health Sciences Authority	09161P